Factorial Characters and Tokuyama's Identity for Classical Groups by Angèle M. Hamel, Ronald C. King

Get full text

Colistin-resistant Klebsiella pneumoniae ST307 clone: Epidemiological, risk factors and massive molecular analysis of bacterial genomes linked to an outbreak in Marseille, France by S. Baron, N. Cassir, M. Hamel, L. Hadjadj, N. Saidani, G. Dubourg, J. Rolain

Get full text

Nonverbal Synchrony: An Indicator of Clinical Communication Quality in Racially-Concordant and Racially-Discordant Oncology Interactions by Lauren M. Hamel, Robert Moulder, Fabian T. Ramseyer, Louis A. Penner, Terrance L. Albrecht, Steven Boker, Susan Eggly

Get full text

Adipose Tissue in Breast Cancer Microphysiological Models to Capture Human Diversity in Preclinical Models by Katie M. Hamel, Trivia P. Frazier, Christopher Williams, Tamika Duplessis, Brian G. Rowan, Jeffrey M. Gimble, Cecilia G. Sanchez

Get full text

DISCO App: study protocol for a randomized controlled trial to test the effectiveness of a patient intervention to reduce the financial burden of cancer in a diverse patient popula... by Lauren M. Hamel, David W. Dougherty, Seongho Kim, Elisabeth I. Heath, Lorna Mabunda, Eyouab Tadesse, RaeAnn Hill, Susan Eggly

Get full text

The DISCO App: A pilot test of a multi-level intervention to reduce the financial burden of cancer through improved cost communication by Lauren M. Hamel, David W. Dougherty, Theresa A. Hastert, Erlene K. Seymour, Seongho Kim, Hadeel Assad, Jasminder Phalore, Roger Soulliere, Susan Eggly

Get full text

Development and pilot test of a physician-focused cancer clinical trials communication training intervention by Susan Eggly, Mark Manning, Nicole Senft, Tanina Foster Moore, Terrance L. Albrecht, Louis A. Penner, Elisabeth Heath, Michael A. Carducci, Dina G. Lansey, Lauren M. Hamel

Get full text

A Review of Research on Disparities in the Care of Black and White Patients With Cancer in Detroit by Michael S. Simon, Michael S. Simon, Sreejata Raychaudhuri, Lauren M. Hamel, Lauren M. Hamel, Louis A. Penner, Louis A. Penner, Kendra L. Schwartz, Kendra L. Schwartz, Felicity W. K. Harper, Felicity W. K. Harper, Hayley S. Thompson, Hayley S. Thompson, Jason C. Booza, Jason C. Booza, Michele Cote, Michele Cote, Ann G. Schwartz, Ann G. Schwartz, Susan Eggly, Susan Eggly

Get full text

Addressing multilevel barriers to clinical trial participation among Black and White men with prostate cancer through the PACCT study by Susan Eggly, Nicole Senft, Seongho Kim, Elisabeth I. Heath, Hyejeong Jang, Tanina F. Moore, Fatmeh Baidoun, Mark A. Manning, Louis A. Penner, Terrance L. Albrecht, Michael A. Carducci, Dina Lansey, Lauren M. Hamel

Get full text

Partnering around cancer clinical trials (PACCT): study protocol for a randomized trial of a patient and physician communication intervention to increase minority accrual to prosta... by Susan Eggly, Lauren M. Hamel, Elisabeth Heath, Mark A. Manning, Terrance L. Albrecht, Ellen Barton, Mark Wojda, Tanina Foster, Michael Carducci, Dina Lansey, Ting Wang, Rehab Abdallah, Narineh Abrahamian, Seongho Kim, Nicole Senft, Louis A. Penner

Get full text

999 The PTPN2/N1 small molecule inhibitor ABBV-CLS-484 promotes NK cell activity driving primary tumor regression and preventing metastasis by Chirag Patel, Meng Sun, Yue Liu, Jonathan Powell, Kyle Halliwill, Jennifer M Frost, Robert T Manguso, Kathleen B Yates, Hakimeh Ebrahimi-Nik, Christina K Baumgartner, Keith M Hamel, Kira Olander, Kathleen A McGuire, Audrey J Muscato, Kelly Klinge, Joseph Klahn, Jacqueline Aguado, Payal Tiwari, Kayla J Colvin, Marcia N Paddock, Philip R Kym, Omar Avila-Monge, Alexander Schutte

Development and internal validation of the multivariable CIPHER (Collaborative Integrated Pregnancy High-dependency Estimate of Risk) clinical risk prediction model by Beth A. Payne, Helen Ryan, Jeffrey Bone, Laura A. Magee, Alice B. Aarvold, J. Mark Ansermino, Zulfiqar A. Bhutta, Mary Bowen, J. Guilherme Cecatti, Cynthia Chazotte, Tim Crozier, Anne-Cornélie J. M. de Pont, Oktay Demirkiran, Tao Duan, Marlot Kallen, Wessel Ganzevoort, Michael Geary, Dena Goffman, Jennifer A. Hutcheon, K. S. Joseph, Stephen E. Lapinsky, Isam Lataifeh, Jing Li, Sarka Liskonova, Emily M. Hamel, Fionnuala M. McAuliffe, Colm O’Herlihy, Ben W. J. Mol, P. Gareth R. Seaward, Ramzy Tadros, Turkan Togal, Rahat Qureshi, U. Vivian Ukah, Daniela Vasquez, Euan Wallace, Paul Yong, Vivian Zhou, Keith R. Walley, Peter von Dadelszen, the CIPHER Group

Get full text

1403-A PTPN2/N1 inhibitor ABBV-CLS-484 unleashes potent anti-tumor immunity by Wei Qiu, Qi Sun, Yi Yang, Chirag Patel, Meng Sun, Yue Liu, Kyle Halliwill, Sarah Kim, Rebecca Mathew, Jennifer M Frost, Jennifer A Roth, Domenick Kennedy, Robert T Manguso, Kathleen B Yates, Hakimeh Ebrahimi-Nik, Christina K Baumgartner, Arvin Iracheta-Vellve, Keith M Hamel, Kira Olander, Thomas GR Davis, Kathleen A McGuire, Geoff T Halvorsen, Omar I Avila, Ashwin V Kammula, Audrey J Muscato, Prasanthi Geda, Kelly Klinge, Zhaoming Xiong, Ryan Duggan, Liang Mu, Mitchell D Yeary, James C Patti, Tyler M Balon, Carey Backus, Angeline Chen, Kenton Longenecker, Joseph Klahn, Cara Hrusch, Navasona Krishnan, Charles W Hutchins, Jacqueline Aguado, Marinka Bulic, Payal Tiwari, Kayla J Colvin, Cun Lan Chuong, Ian C Kohnle, Matthew G Rees, Andrew Boghossian, Melissa Ronan, Meng-Ju Wu, Debattama R Sen, Gabriel K Griffin, Nabeel El-Bardeesy, Patricia Trusk, Joshua H Decker, Stacey Fossey, Marcia N Paddock, Elliot P Farney, Clay Beauregard, Philip R Kym